aod9604 troches Platinum Peptides UK AOD-9604 failed its FDA trials

Stability allows 12 months unopened storage at 2-8C and 60 days post-reconstitution

We offer methylcobalamin (the active, methylated form, our default), hydroxocobalamin (a longer-acting storage form), and combination shots including MIC Lipo, glutathione, B-complex, Tri-Immune, and Vitamin D injections

A large 24-week trial involving 536 participants failed to demonstrate statistically significant weight loss compared to placebo when combined with diet and exercise

Neither replaces the other

Stacking & Combinations Because its mechanism is NAD+ preservation, the logical research pairing is with the NAD+ pathway : in some research framings, an NNMT inhibitor like 5-Amino-1MQ is discussed alongside NAD+ precursors, on the reasoning that inhibiting the enzyme that drains NAD+ and supplying more NAD+ substrate address the same bottleneck from two directions

The current evidence is therefore insufficient to support therapeutic claims for 5-Amino-1MQ in people